Lipopolysaccharide, CD14 and Toll-like receptors: an emerging link between innate immunity and atherosclerotic disease

Author： Shimada Kazunori   Daida Hiroyuki   Ma-Krupa Wei   Goronzy Jörg J   Weyand Cornelia M  

Publisher： Future Medicine

ISSN： 1479-6678

Source： Future Cardiology, Vol.1, Iss.5, 2005-09, pp. : 657-674

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Innate Immunity, Toll-Like Receptors, and Diabetes

By  

Current Immunology Reviews, Vol. 5, Iss. 2, 2009-05 ,pp. : 111-121

Bentham Science Publishers

Access to resources Recommend Favorite

Endotoxin, Toll-like Receptor-4, and Atherosclerotic Heart Disease

By  

Current Cardiology Reviews, Vol. 13, Iss. 2, 2017-03 ,pp. : 86-93

Bentham Science Publishers

Access to resources Recommend Favorite

Toll-Like Receptors in Gastrointestinal Diseases

By  

Digestive Diseases, Vol. 30, Iss. 1, 2012-10 ,pp. : 74-77

Karger

Access to resources Recommend Favorite

The c.1-260C>T Promoter Variant of CD14 but Not the c.896A>G (p.D299G) Variant of Toll-Like Receptor 4 (TLR4) Genes Is Associated with Inflammatory Bowel Disease

By  

Digestion, Vol. 76, Iss. 3-4, 2007-12 ,pp. : 196-202

Karger

Access to resources Recommend Favorite

Toll-Like Receptors Mediated Signalings: Friends or Enemies?

By Zhang Yan  

Digestive Diseases and Sciences, Vol. 58, Iss. 10, 2013-10 ,pp. : 2746-2747

Springer Publishing Company

Access to resources Recommend Favorite